Maven Securities LTD P Lx Pharma Inc. Transaction History

Maven Securities LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.69 - $19.66 $1.54 Million - $3.94 Million	-200,377 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$12.22 - $21.28 $3.66 Million - $6.38 Million	-299,623 Reduced 59.92%	200,377 $3.87 Million
Q2 2021 Aug 16, 2021	BUY	$9.0 - $15.94 $4.5 Million - $7.97 Million	500,000 New	500,000 $6.52 Million

62.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.